Dr. Kottilil is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 W Lombard St
Baltimore, MD 21201Phone+1 410-328-9102Fax+1 410-706-4619
Education & Training
- National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2000 - 2002
- Brown UniversityResidency, Internal Medicine, 1997 - 2000
- Government Medical College ThrissurClass of 1991
Certifications & Licensure
- MD State Medical License 2014 - 2026
- DC State Medical License 2009 - 2024
- VA State Medical License 2001 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV Start of enrollment: 1993 Mar 09
- Open Label Study to Evaluate Chronic Hepatitis C Treatment in Latino Subjects With and Without HIV Co-infection Start of enrollment: 2010 Jul 01
- Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection Start of enrollment: 2011 Aug 23
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsSafety and efficacy of the oral TLR8 agonist selgantolimod in individuals with chronic hepatitis B under viral suppression.Edward J Gane, P Rod Dunbar, Anna E Brooks, Fangqiu Zhang, Diana Chen
Journal of Hepatology. 2023-03-01 - 58 citationsOld vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics.Konstantin Chumakov, Michael S. Avidan, Christine Stabell Benn, Stefano M. Bertozzi, Lawrence Blatt
Proceedings of the National Academy of Sciences of the United States of America. 2021-05-25 - 299 citationsNatural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlatesDomenico Mavilio, Janet Benjamin, Marybeth Daucher, Gabriella Lombardo, Shyam Kottilil
Proceedings of the National Academy of Sciences of the United States of America. 2003-12-09
Press Mentions
- Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients with Unfavorable Treatment CharacteristicsA Randomized Clinical TrialSeptember 19th, 2019
- UM School of Medicine Awarded Nearly $30 Million to Improve Health Outcomes of IV Drug UsersDecember 13th, 2023
- UM School of Medicine Awarded Nearly $30 Million to Prevent Infections Associated with IV Drug UseDecember 21st, 2023
Grant Support
- Therapeutic Strategies For The Management Of HCV/HIV CO-National Institute Of Allergy And Infectious Diseases2006
- Role Of Innate Immunity In The Initiation And PathogenesNational Institute Of Allergy And Infectious Diseases2006
Professional Memberships
- Master
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: